Gabexate

Gabexate
Clinical data
AHFS/Drugs.com International Drug Names
ATC code none
Identifiers
CAS Number 39492-01-8 YesY
PubChem (CID) 3447
IUPHAR/BPS 7863
ChemSpider 3329 N
UNII 4V7M9137X9 YesY
KEGG D08004 YesY
ChEMBL CHEMBL87563 N
Chemical and physical data
Formula C16H23N3O4
Molar mass 311.37 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Gabexate is a serine protease inhibitor which is used therapeutically (as gabexate mesilate) in the treatment of pancreatitis, disseminated intravascular coagulation,[1] and as a regional anticoagulant for haemodialysis.[2]

References

  1. Yuksel M, Okajima K, Uchiba M, Okabe H (2003). "Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes" (PDF). J. Pharmacol. Exp. Ther. 305 (1): 298–305. doi:10.1124/jpet.102.041988. PMID 12649382.
  2. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V (1996). "Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group" (PDF). N. Engl. J. Med. 335 (13): 919–23. doi:10.1056/NEJM199609263351302. PMID 8786777.


This article is issued from Wikipedia - version of the 12/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.